Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03337139 · ClinicalTrials.gov registry record · NA
FitLink: Improving Weight Loss Maintenance by Using Digital Data to Provide Support and Accountability
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT03337139: Completed NA study, sponsored by Drexel University.
NCT03337139 is a NA study that has completed, run by Drexel University. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03337139, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
Most adults in the U.S. are overweight or obese and find maintenance of weight loss difficult. This study is designed to aid in the development of a lifestyle modification program that can facilitate weight loss maintenance, without requiring long-term visits to a clinic for maintenance treatment.
Primary Outcome
Objectively measured in the research clinic at each time point on a scale. Reported as weight change in kg, where negative numbers reflect weight loss and positive numbers reflect weight gain.
Interventions
- BEHAVIORAL Gold Standard Behavior Therapy for Weight Loss
- BEHAVIORAL Standard Remote Behavior Therapy for Weight Loss
- BEHAVIORAL Digital Data Sharing Behavior Therapy for Weight Loss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2017-11-17 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
What the finished NCT03337139 record still lists
NCT03337139 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Gold Standard Behavior Therapy for Weight Loss is the first listed.
NCT03337139 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03337139 about?
NCT03337139 is a clinical study titled "FitLink: Improving Weight Loss Maintenance by Using Digital Data to Provide Support and Accountability". Most adults in the U.S. are overweight or obese and find maintenance of weight loss difficult. This study is designed to aid in the development of a lifestyle modification program that can facilitate weight loss maintenance, without requiring long-term visits to a clinic for maintenance treatment.
What is the current status of trial NCT03337139?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2017-11-17. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03337139?
The interventions under investigation include: Gold Standard Behavior Therapy for Weight Loss (BEHAVIORAL), Standard Remote Behavior Therapy for Weight Loss (BEHAVIORAL), Digital Data Sharing Behavior Therapy for Weight Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT03337139?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03337139's enrollment target sits among peer trials
87 974th of 2000 higher than 1,025 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI